China Drug Approvals | 2023 | NMPA Drug Approvals | Pharma | Healthcare | China | iPharmaCenter
China's National Medical Products Administration (NMPA) has accepted Astellas Pharma's Xtandi (enzalutamide) New Drug Application (NDA)...
top of page
bottom of page